Biomaterials companies

  • Report ID: 1375
  • Published Date: Jun 26, 2025
  • Report Format: PDF, PPT

Key Biomaterials Market Players:

    The global market is competitive with the leading players focusing on innovation, strategic collaboration, and R&D development. Companies such as Johnson & Johnson and Medtronic in the U.S. dominate the cardiovascular and orthopedic segments, whereas Europe-based companies such as DSM and Evonik focus on polymers and tissue regeneration. Manufacturers including Samyang Biopharm and Terumo are making significant investments in biodegradable implants and drug-eluting technology. The global market is transforming, with new income streams being created by strategic alliances such as Tata Chemicals' foray into sustainable biomaterials and Zimmer Biomet's 2023 cooperation with biotech entrepreneurs.

    The top 20 cohort of such key players include: 

    Company Name

    Country

    Industry Focus

    Estimated Global Market Share (%)

    Johnson & Johnson

    U.S.

    Orthopedic, dental, and cardiovascular biomaterials

    9.9%

    Medtronic

    U.S.

    Cardiovascular and neural implant biomaterials

    8.7%

    Zimmer Biomet

    U.S.

    Orthopedic biomaterials including bone cement and resorbables

    6.6%

    Stryker Corporation

    U.S.

    Surgical implants, trauma biomaterials, 3D printing

    6.2%

    DSM Biomedical

    Netherlands

    Collagen-based biomaterials, resorbable polymers

    4.7%

    Evonik Industries

    Germany

    Polymeric biomaterials for drug delivery and coatings

    xx%

    BASF SE

    Germany

    Biodegradable polymers, implant coatings

    xx%

    Corbion

    Netherlands

    PLA biomaterials for controlled drug delivery and regenerative therapy

    xx%

    Covalon Technologies

    Canada

    Antimicrobial wound dressings and coatings

    xx%

    Mitsui Chemicals

    Japan

    Dental and surgical bioresorbables

    xx%

    Terumo Corporation

    Japan

    Cardiovascular biomaterials and injectable systems

    xx%

    Invibio Ltd (Victrex)

    UK

    PEEK biomaterials for spine and orthopedic surgery

    xx%

    Noble Biomaterials

    USA

    Antimicrobial coatings and wound care biomaterials

    xx%

    Orthocell Ltd

    Australia

    Collagen scaffolds for musculoskeletal repair

    xx%

    Bioretec Ltd

    Finland

    Pediatric orthopedic bioabsorbables

    xx%

    Samyang Biopharm

    South Korea

    Biodegradable surgical implants

    xx%

    BioAlpha Holdings Bhd

    Malaysia

    Marine-derived biomaterials

    xx%

    Tata Chemicals Ltd

    India

    Bioscaffold R&D and bio-derived industrial materials

    xx%

    Collagen Solutions

    UK

    Collagen-based regenerative materials

    xx%

    Straumann Group

    Switzerland

    Dental biomaterials and tissue regeneration systems

    xx%

    Below are the areas covered for each company in the biomaterials market:

    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of biomaterials is estimated at USD 154.9 billion.

Biomaterials Market size was valued at USD 143.5 billion in 2024 and is likely to cross USD 373.8 billion by 2034, registering more than 7.9% CAGR during the forecast period i.e., between 2025-2034.

North America is poised to account for largest industry share by 2034.

The key market players include Covestro AG, HMA Group Holdings, LLC, Victrex plc, Corbion N.V., Mitsubishi Chemical Group Holdings, AB Specialty Silicones, LLC, CeramTec GmbH, Olympus Corporation, Gelita AG, Evonik Industries AG.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos